The South Korean man infected with MERS virus, the first case in 3 years
A South Korean man, 61, was diagnosed with the potentially deadly Middle East Respiratory Syndrome (MERS) and is being treated at a hospital in Seoul, the Korea Centers for Disease Control and Prevention (KCDC) said on Saturday. The patient returned to Seoul on Friday after a business trip to Kuwait from August 16 to Sept. 6, according to the KCDC.
Japan's agriculture ministry said on Sunday it had confirmed the country's first outbreak of swine fever in 26 years and suspended exports of pork and wild boar meat. The fever, a different kind from the African swine fever that has broken out in China, was found in a farm in central Japan's Gifu city, the ministry said.
A cholera outbreak has killed 10 people in Zimbabwe's capital Harare after they drank contaminated water, a city health official said on Sunday. Harare city council has struggled to supply water to some suburbs for more than a decade, forcing residents to rely on water from open wells and community boreholes.
HIV prevention pill reaching more people who need it
More than one in nine people worldwide who might benefit from a daily pill to minimize their risk of getting HIV are now taking this medicine, a research review suggests. So-called HIV pre-exposure prophylaxis (PrEP) is highly protective against HIV, but many people worldwide don't get this pill because they aren't aware of it or because it's unavailable or unaffordable.
Two health scares at U.S. airports tied to Mecca pilgrims: U.S. officials
Two major health scares at U.S. airports involving inbound flights are related to pilgrims returning from the Hajj, the Muslim pilgrimage to the holy city of Mecca, Saudi Arabia, which ended in late August, U.S. health officials said on Friday. On Wednesday, U.S. health officials sent an emergency response team with mobile diagnostic equipment to John F. Kennedy International Airport in New York after they were told that more than 100 passengers aboard an Emirates airlines flight from Dubai were experiencing flu-like symptoms.
GSK says U.S. FDA wants more information on pulmonary drug
GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD). GSK said it had received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its application for mepolizumab - the generic name for Nucala - as an add-on treatment to inhaled corticosteroid-based maintenance treatment.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)